Bill Gates doesn't expect a virus vaccine before year-end — but he says one drugmaker has the best chance

"We do see good antibody levels both in the phase one and the phase two (trials), so we're pretty hopeful," Gates told CNBC.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.